Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
In our authors' reply to the letter by Barber and
Thompson, we stated that further analysis of our data, using their recommended t test on bootstrapped data, had confirmed the
results of the non-parametric tests used in our original
article.1-3 In other words, open access follow up for
irritable bowel disease led to cost savings in secondary care. We have
since discovered that a calculation error occurred in our
bootstrapping exercise. The further analysis did not, in fact,
confirm the statistical significance reported for secondary care,
although it did confirm the original result that differences in overall
costs (primary, secondary plus patient-borne costs) were not
significant. We accept that bootstrapping is the preferred approach and
that, on this basis, the study did not demonstrate resource savings
in secondary care.
It is unfortunate that Bland's letter, published on bmj.com
(bmj.com/cgi/eletters/320/7251/1730#8480) and in the
journal,4 draws attention to